Bastet 101

NASH initiation and progression is very complex.

Blocking multiple pathways will increase efficacy across a diverse population and disease pathogenisis.

Inhibits lipid synthesis by regulating the SREP1 pathway

Accelerates lipid oxidation/breakdown by binding PPAR-alpha which can modulate PPAR-gamma

Inhibits inflammation

Mitigates oxidative stress by having strong anti-oxidant activity